- Stocks
- Healthcare
- NYSE: STE

Price (delayed)

$231.86

Market cap

$23.19B

P/E Ratio

81.64

Dividend/share

$1.66

EPS

$2.84

Enterprise value

$26.45B

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been

The company's equity has surged by 79% YoY

The revenue has grown by 27% YoY and by 13% from the previous quarter

STERIS's quick ratio has increased by 30% from the previous quarter but it has decreased by 22% YoY

STE's P/E is 102% above its 5-year quarterly average of 40.4 and 55% above its last 4 quarters average of 52.8

The company's EPS fell by 43% YoY and by 16% QoQ

What are the main financial stats of STE

Market
Valuations
Earnings

Shares outstanding

100.02M

Market cap

$23.19B

Enterprise value

$26.45B

Price to earnings (P/E)

81.64

Price to book (P/B)

3.54

Price to sales (P/S)

6.01

EV/EBIT

65.74

EV/EBITDA

36.75

EV/Sales

6.87

Revenue

$3.85B

EBIT

$402.35M

EBITDA

$719.87M

Free cash flow

$401.13M

Per share
Balance sheet
Liquidity

EPS

$2.84

Free cash flow per share

$4.02

Book value per share

$65.51

Revenue per share

$38.57

TBVPS

$36.74

Total assets

$11.75B

Total liabilities

$5.21B

Debt

$3.64B

Equity

$6.54B

Working capital

$1.12B

Debt to equity

0.56

Current ratio

2.42

Quick ratio

1.46

Net debt/EBITDA

4.53

Margins
Efficiency
Dividend

EBITDA margin

18.7%

Gross margin

42.5%

Net margin

6.5%

Operating margin

11%

Return on assets

2.7%

Return on equity

4.8%

Return on invested capital

8.3%

Return on capital employed

3.7%

Return on sales

10.5%

Dividend yield

0.72%

DPS

$1.66

Payout ratio

58.5%

How has the STERIS stock price performed over time

Intraday

0.64%

1 week

-4.06%

1 month

-0.29%

1 year

22.87%

YTD

-4.75%

QTD

-4.75%

How have STERIS's revenue and profit performed over time

Revenue

$3.85B

Gross profit

$1.63B

Operating income

$423.93M

Net income

$251.36M

Gross margin

42.5%

Net margin

6.5%

STERIS's net margin has plunged by 54% YoY and by 23% from the previous quarter

The company's net income fell by 41% YoY and by 13% QoQ

STE's operating margin is down by 40% year-on-year and by 17% since the previous quarter

The revenue has grown by 27% YoY and by 13% from the previous quarter

What is STERIS's growth rate over time

What is STERIS stock price valuation

P/E

81.64

P/B

3.54

P/S

6.01

EV/EBIT

65.74

EV/EBITDA

36.75

EV/Sales

6.87

STE's P/E is 102% above its 5-year quarterly average of 40.4 and 55% above its last 4 quarters average of 52.8

The company's EPS fell by 43% YoY and by 16% QoQ

The company's equity has surged by 79% YoY

STE's P/B is 11% above its 5-year quarterly average of 3.2

The P/S is 50% above the 5-year quarterly average of 4.0 and 16% above the last 4 quarters average of 5.2

The revenue has grown by 27% YoY and by 13% from the previous quarter

How efficient is STERIS business performance

STERIS's ROA has plunged by 65% YoY and by 27% from the previous quarter

The ROE has plunged by 61% YoY and by 25% from the previous quarter

STERIS's ROIC has plunged by 57% YoY and by 22% from the previous quarter

The company's return on sales fell by 44% YoY and by 17% QoQ

What is STE's dividend history

DPS

$1.66

Dividend yield

0.72%

Payout ratio

58.5%

Recent dividends

How did STERIS financials performed over time

The total assets is 126% more than the total liabilities

STE's total liabilities has surged by 185% year-on-year but it is down by 6% since the previous quarter

The total assets has soared by 114% YoY but it has contracted by 2.9% from the previous quarter

STERIS's debt is 44% less than its equity

The company's equity has surged by 79% YoY

STE's debt to equity has surged by 75% year-on-year but it is down by 3.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.